lovastatin has been researched along with Basophilic Leukemia, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Foutz, T; Graham, TE; Kusewitt, DF; Lee, RJ; Martinez, AM; Oliver, JM; Pfeiffer, JR; Wilson, BS | 1 |
1 other study(ies) available for lovastatin and Basophilic Leukemia, Acute
| Article | Year |
|---|---|
MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling.
Topics: Alkyl and Aryl Transferases; Animals; Benzodiazepines; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; Enzyme Activation; Enzyme Inhibitors; Farnesyltranstransferase; Immunoglobulin E; Inositol 1,4,5-Trisphosphate; Isoenzymes; Leukemia, Basophilic, Acute; Lovastatin; Mast Cells; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neoplasm Proteins; Oligopeptides; Phospholipase C gamma; Protein Isoforms; Protein Prenylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-raf; ras Proteins; Rats; Receptors, IgE; Signal Transduction; Tumor Cells, Cultured; Type C Phospholipases | 1998 |